Cologne, Germany-based Cannamedical is recalling a batch of cannabis flower after contamination above acceptable levels was detected, Marijuana Business Daily has learned.
This is at least the third cannabis recall this summer in Germany.
“On Tuesday, Cannamedical voluntarily started a recall of one batch of flower of our ‘Sativa’ variety because contamination has been detected by two of our pharmacy clients as well as in some product containers reviewed by our quality assurance team,” David Henn, CEO of the German independent wholesaler, told MJBizDaily.
According to Henn, the products were sold to pharmacies between July 21 and Aug. 29. The batch number is CMMA20FSSM071456.
“We have informed our respective authorities and made the mandatory announcement to the Drug Commission of German Pharmacists (AMK),” the CEO said. “We take this very seriously as we aim to ensure the biggest possible quality for our patients at all time.”
Pharmacies are encouraged to inform Cannamedical of any product they might have of the affected batch. The distributor will then pick up the affected products and provide replacements.
While Henn recognized the event would be expensive for the company, he told Marijuana Business Daily that “it is for things like these that we have strict guidelines which, as expected, resulted in a quick and simple recall and replacement campaign with our clients.”
The flower affected was imported from Canada and produced in a European Union-Good Manufacturing Practice-certified facility, Henn said.
The Canadian producer was not identified.
Unlike most flower available in the German market, Cannamedical flower imports from Canada are not irradiated to reduce contamination.
“We believe non-irradiated flower is an important differentiator in this market,” Henn said. “We have trained our suppliers to produce in accordance with the German requirements and are continuously exploring ways to lower the chances of possible recalls.”
Alfredo Pascual can be reached at email@example.com